Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term Open-label Non-comparative Study of Tacrolimus in Stable Pediatric Allograft Recipients
2009-012259-21Phase 4Terminated
- Sponsor
- Astellas Pharma
- Start
- Jan 2011
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of tacrolimus in Cardiac Rejection (2 arms), sponsored by Astellas Pharma. Primary endpoint: F506-CL-0404A variables. Started Jan 2011; status: terminated.
02
Drugs
tacrolimus
03
Conditions
Cardiac Rejection
Beyond the preview
Go deeper on 2009-012259-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-012259-21.